Ceyda Karadeniz

1.3k total citations
65 papers, 923 citations indexed

About

Ceyda Karadeniz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ceyda Karadeniz has authored 65 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Ceyda Karadeniz's work include Lymphoma Diagnosis and Treatment (8 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Ceyda Karadeniz is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Ceyda Karadeniz collaborates with scholars based in Türkiye, Canada and United States. Ceyda Karadeniz's co-authors include Aynur Oğuz, Faruk Güçlü Pınarlı, Elvan Çağlar Çıtak, Arzu Okur, Sedat Çeti̇ner, Gökhan Alpaslan, Cansu Alpaslan, Fatma Visal Okur, Alev Hasanoğlu and Türkiz Gursel and has published in prestigious journals such as Journal of Clinical Oncology, Supportive Care in Cancer and European Journal Of Oral Sciences.

In The Last Decade

Ceyda Karadeniz

62 papers receiving 886 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ceyda Karadeniz 250 250 185 179 177 65 923
Aynur Oğuz 224 0.9× 211 0.8× 169 0.9× 178 1.0× 184 1.0× 56 856
Mikko Perkkiö 101 0.4× 159 0.6× 233 1.3× 95 0.5× 175 1.0× 45 1.1k
J. Roger Hollister 198 0.8× 165 0.7× 92 0.5× 133 0.7× 145 0.8× 18 1.1k
Je Hwan Won 446 1.8× 111 0.4× 97 0.5× 66 0.4× 587 3.3× 89 1.1k
Maria Casteels‐Van Daele 170 0.7× 85 0.3× 81 0.4× 105 0.6× 166 0.9× 53 934
Martin Mohren 55 0.2× 188 0.8× 75 0.4× 185 1.0× 115 0.6× 37 936
Yi‐Kong Keung 112 0.4× 111 0.4× 72 0.4× 74 0.4× 88 0.5× 55 820
Maria Boratyńska 172 0.7× 245 1.0× 85 0.5× 85 0.5× 541 3.1× 120 1.4k
E. M. Berkman 92 0.4× 156 0.6× 71 0.4× 62 0.3× 120 0.7× 43 1.1k
Pekka Arikoski 351 1.4× 202 0.8× 258 1.4× 65 0.4× 193 1.1× 44 1.1k

Countries citing papers authored by Ceyda Karadeniz

Since Specialization
Citations

This map shows the geographic impact of Ceyda Karadeniz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ceyda Karadeniz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ceyda Karadeniz more than expected).

Fields of papers citing papers by Ceyda Karadeniz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ceyda Karadeniz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ceyda Karadeniz. The network helps show where Ceyda Karadeniz may publish in the future.

Co-authorship network of co-authors of Ceyda Karadeniz

This figure shows the co-authorship network connecting the top 25 collaborators of Ceyda Karadeniz. A scholar is included among the top collaborators of Ceyda Karadeniz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ceyda Karadeniz. Ceyda Karadeniz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pınarlı, Faruk Güçlü, Faruk Güçlü Pınarlı, Ferda Alpaslan Pınarlı, et al.. (2018). Epigenetic silencing of the tumor suppressor genesSPI1, PRDX2, KLF4, DLEC1, andDAPK1in childhood and adolescent lymphomas. Pediatric Hematology and Oncology. 35(2). 131–144. 15 indexed citations
3.
4.
Pınarlı, Ferda Alpaslan, Ferda Alpaslan Pınarlı, Nilüfer N. Turan, et al.. (2013). Resveratrol and Adipose-derived Mesenchymal Stem Cells Are Effective in the Prevention and Treatment of Doxorubicin Cardiotoxicity in Rats. Pediatric Hematology and Oncology. 30(3). 226–238. 38 indexed citations
5.
Pınarlı, Faruk Güçlü, Zühre Kaya, Aynur Oğuz, et al.. (2012). High-Risk ALK Negative Anaplastic Large-Cell Lymphoma Presenting with Hypereosinophilic Syndrome in a 2.5-Year-Old Child. Pediatric Hematology and Oncology. 29(8). 686–690. 1 indexed citations
6.
Pınarlı, Faruk Güçlü, Aynur Oğuz, Ceyda Karadeniz, et al.. (2012). Institutional experience of paediatric high-grade central nervous system tumours: An analysis of 74 patients and review of the literature. Współczesna Onkologia. 1(1). 26–33. 1 indexed citations
7.
Yıldırım, Ayşe, F. Sedef Tunaoğlu, Faruk Güçlü Pınarlı, et al.. (2010). The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 10(2). 154–162. 3 indexed citations
8.
Karadeniz, Ceyda. (2009). Çocukluk Çağının Germ Hücreli Tümörleri. 5(4). 101–110. 1 indexed citations
9.
Pınarlı, Faruk Güçlü, et al.. (2008). Late relapsing Wilms tumor with rhabdomyomatous differentiation. Pediatric Blood & Cancer. 52(5). 675–677. 4 indexed citations
10.
Çıtak, Elvan Çağlar, et al.. (2008). Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma. Pathology - Research and Practice. 204(2). 89–96. 11 indexed citations
11.
Çıtak, Elvan Çağlar, et al.. (2008). MANAGEMENT OF PLEXIFORM NEUROFIBROMA WITH INTERFERON ALPHA. Pediatric Hematology and Oncology. 25(7). 673–678. 11 indexed citations
12.
Oğuz, Aynur, et al.. (2006). WHICH ONE IS A RISK FACTOR FOR CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA IN CHILDHOOD SOLID TUMORS: Early Lymphopenia or Monocytopenia?. Pediatric Hematology and Oncology. 23(2). 143–151. 18 indexed citations
13.
Oğuz, Aynur, Faruk Güçlü Pınarlı, Ceyda Karadeniz, Aysun Bıdecı, & Síbel A. Özkan. (2006). Late effects of treatment on growth in childhood non-Hodgkin's lymphoma. Leukemia & lymphoma. 47(7). 1283–1289. 1 indexed citations
14.
Oğuz, Aynur, et al.. (2006). EVALUATION OF PERIPHERAL LYMPHADENOPATHY IN CHILDREN. Pediatric Hematology and Oncology. 23(7). 549–561. 54 indexed citations
15.
Oğuz, Aynur, Ceyda Karadeniz, Fatma Visal Okur, et al.. (2005). Prognostic factors and treatment outcome in childhood hodgkin disease. Pediatric Blood & Cancer. 45(5). 670–675. 22 indexed citations
16.
Oğuz, Aynur, Sedat Çeti̇ner, Ceyda Karadeniz, et al.. (2004). Long‐term effects of chemotherapy on orodental structures in children with non‐Hodgkin's lymphoma. European Journal Of Oral Sciences. 112(1). 8–11. 56 indexed citations
17.
Karadeniz, Ceyda, et al.. (2000). PRIMARY PLEURAL LYMPHOMA: An Unusual Presentation of Childhood Non-Hodgkin Lymphoma. Pediatric Hematology and Oncology. 17(8). 695–699. 9 indexed citations
18.
Karadeniz, Ceyda, et al.. (1999). THE ETIOLOGY OF PERIPHERAL LYMPHADENOPATHY IN CHILDREN. Pediatric Hematology and Oncology. 16(6). 525–531. 28 indexed citations
19.
Oğuz, Aynur, et al.. (1999). ARM ANTHROPOMETRY IN EVALUATION OF MALNUTRITION IN CHILDREN WITH CANCER. Pediatric Hematology and Oncology. 16(1). 35–41. 55 indexed citations
20.
Karadeniz, Ceyda, Sevgül Bilgiç, Şevket Ruacan, et al.. (1991). Primary subconjunctival lymphoma: An unusual presentation of childhood non‐Hodgkin's lymphoma. Medical and Pediatric Oncology. 19(3). 204–207. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026